caprylates has been researched along with Deep Vein Thrombosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hull, R; Marder, V; Pineo, G | 1 |
| Baughman, RA; Gonze, MD; Leone-Bay, A; Money, SR; Salartash, K; Sternbergh, WC | 1 |
| Money, SR; York, JW | 1 |
2 review(s) available for caprylates and Deep Vein Thrombosis
| Article | Year |
|---|---|
Oral delivery of heparin: SNAC and related formulations.
Topics: Arthroplasty, Replacement, Knee; Caprylates; Chemistry, Pharmaceutical; Heparin; Humans; Venous Thrombosis | 2004 |
Development of oral heparin therapy for prophylaxis and treatment of deep venous thrombosis.
Topics: Administration, Oral; Anticoagulants; Antithrombin III; Biological Availability; Caprylates; Chemistry, Pharmaceutical; Decanoates; Disease Models, Animal; Drug Carriers; Drug Evaluation, Preclinical; Heparin; Humans; Hydroxybenzoates; Intestinal Absorption; Treatment Outcome; Venous Thrombosis | 2001 |
1 other study(ies) available for caprylates and Deep Vein Thrombosis
| Article | Year |
|---|---|
Orally administered unfractionated heparin with carrier agent is therapeutic for deep venous thrombosis.
Topics: Administration, Oral; Animals; Anticoagulants; Caprylates; Disease Models, Animal; Drug Carriers; Enoxaparin; Injections, Subcutaneous; Jugular Veins; Male; Partial Thromboplastin Time; Rats; Rats, Sprague-Dawley; Venous Thrombosis | 2000 |